Source: World Journal of Gastroenterology. Unidades: FMRP, EERP
Subjects: LACTOBACILLUS, COLITE, NEOPLASIAS COLORRETAIS, CARCINOGÊNESE, PROBIÓTICOS, INFLAMAÇÃO
ABNT
SILVEIRA, Denise Sayuri Calheiros da et al. Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model. World Journal of Gastroenterology, v. 26, n. 43, p. 6782-6794, 2020Tradução . . Disponível em: https://doi.org/10.3748/wjg.v26.i43.6782. Acesso em: 14 nov. 2024.APA
Silveira, D. S. C. da, Veronez, L. C., Lopes Junior, L. C., Anatriello, E., Brunaldi, M. O., & Bisson, G. S. (2020). Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model. World Journal of Gastroenterology, 26( 43), 6782-6794. doi:10.3748/wjg.v26.i43.6782NLM
Silveira DSC da, Veronez LC, Lopes Junior LC, Anatriello E, Brunaldi MO, Bisson GS. Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model [Internet]. World Journal of Gastroenterology. 2020 ; 26( 43): 6782-6794.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3748/wjg.v26.i43.6782Vancouver
Silveira DSC da, Veronez LC, Lopes Junior LC, Anatriello E, Brunaldi MO, Bisson GS. Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model [Internet]. World Journal of Gastroenterology. 2020 ; 26( 43): 6782-6794.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3748/wjg.v26.i43.6782